Matt Marin, Founding Partner, Marin & Murphy Law Firm
Free, No-Obligation Hair Relaxer Claim Review
Free Confidential Consultation

No fee unless there is a recovery. Court costs and litigation expenses are advanced by counsel and repaid from the recovery. You are not responsible for court costs or litigation expenses if there is no recovery, unless a court directs otherwise. The attorney’s fee is a percentage of the gross recovery, calculated before expenses are deducted.

Hair Relaxer Lawsuit — Free, Confidential Consultation

Years of relaxers, then ovarian cancer.

One of the three diagnoses the federal trials are built on. If you got relaxers regularly for years, find out where you stand.

Active litigation — no settlement. MDL 3060 underway · 11,779 cases pending · filing deadlines vary by state and run from when you knew or should have known.

Did you get relaxers — perms, the white cream — every few weeks, for years?

That one question decides most of it. It seems like nobody ever told you the risk was anything worse than a scalp burn.

See where I standfree · confidential · 2 minutes · an honest answer either way
What the lawsuit is actually about →

No receipts needed · you don’t have to remember every brand · no fee unless there is a recovery. Court costs and litigation expenses are advanced by counsel and repaid from the recovery. You are not responsible for court costs or litigation expenses if there is no recovery, unless a court directs otherwise. The attorney’s fee is a percentage of the gross recovery, calculated before expenses are deducted.

Marin & Murphy Law Firm attorneyOr talk to a person now: (888) 348-2735 — answered 24/7

Attorneys of Marin & Murphy Law Firm

Marin & Murphy Law Firm

Every inquiry gets a personal review and a straight answer — including “not yet” or “no” — free and without obligation.

Claims are brought against the companies that made and sold chemical relaxers — not against your stylist, your salon, or the person who did your hair growing up. Conversations are confidential. Some matters may be referred to or handled with other law firms. No settlement has been announced and no trial has been held; every case depends on its own facts. This page does not diagnose anything. Attorney Advertising.

Ovarian cancer is one of the three core injuries in the federal hair relaxer litigation. Women diagnosed after years of regular chemical relaxer use may have an individual claim, and ovarian cancer cases sit on the same trial track as uterine cancer cases.

One question decides most of it.

Did you get relaxers — perms, the white cream — at least four times a year for two years or more? Roughly is fine.

See where I stand

free · confidential · no receipts needed · you don’t have to remember every brand · an honest answer either way · no fee unless there is a recovery.

The attorney’s fee is a percentage of the gross recovery, calculated before case expenses are deducted. Case expenses are advanced by the firm and reimbursed to the firm out of the recovery only if there is a recovery. You have no liability for court costs or litigation expenses if there is no recovery, unless a court directs otherwise.

This page is about a lawsuit — it is legal information, not medical advice, and it does not diagnose anything. Questions about your health belong with your own doctor.

Free, Confidential Consultation — no fee unless there is a recovery

Talk to Marin & Murphy Law Firm at (888) 348-2735 — answered 24/7 — or use the confidential case review form on this page. Some matters may be referred to or handled with other law firms.

The attorney’s fee is a percentage of the gross recovery, calculated before case expenses are deducted. Case expenses are advanced by the firm and reimbursed to the firm out of the recovery only if there is a recovery. You have no liability for court costs or litigation expenses if there is no recovery, unless a court directs otherwise.

Lawsuits consolidated in federal court in Chicago (MDL 3060) allege that long-term use of chemical hair relaxers is associated with uterine cancer, ovarian cancer, and related conditions. As of August 2026 the cases are in pretrial proceedings; no trial has been held and no settlement has been announced. The allegations have not been proven, and each case depends on its own facts.

2.19ovarian cancer hazard ratio, NIH Sister Study, Carcinogenesis 2021
11,779cases pending in MDL 3060, JPML report 8/3/2026
Nov 13, 2024trial-track order naming the core injuries, MDL 3060 Dkt. 946
0 trials · 0 settlementsas of August 2026

Where ovarian cancer stands in the litigation

The federal court has named ovarian cancer as a core injury twice in ways that matter. In its November 13, 2024 memorandum opinion (Dkt. 946), the court preserved a six-month refiling window for plaintiffs later diagnosed with “uterine, ovarian, or endometrial cancer” — filing only in the federal MDL 3060, with a complete Plaintiff Fact Sheet served within ten business days. And in a June 2026 order setting bellwether damages limits, the court wrote of “the … MDL injury (i.e., ovarian or uterine cancer)” (Dkt. 1944).

The ten bellwether trial cases the court chose for itself on April 2, 2026 (Dkt. 1781) are drawn from that group. Those cases are the ones with expert deadlines running now: case-specific expert discovery closes November 16, 2026, and summary judgment and remaining expert motions are due December 16, 2026 (Dkt. 1778).

One ruling overshadows the calendar. Defendants moved on May 5, 2026 to exclude the plaintiffs’ general-causation experts (Dkt. 1828). Briefing finished June 16, 2026. The motion is undecided and the court has said it will set a hearing later (Dkt. 1881). How that comes out shapes everything downstream, in either direction — and honest pages say so rather than promising a result.

What the research found on ovarian cancer

None of this research existed in any form you would have run into while you were using these products. For most women the only risk anyone ever named was a scalp burn; that is what the box warned about, and there was nothing else in general circulation to know.

The key study is White and colleagues, published in Carcinogenesis in 2021, drawing on the NIH Sister Study cohort: 40,559 women, mean follow-up about ten years, 241 incident ovarian cancers. Comparing frequent users — more than four times a year — of straightener, relaxer or pressing products with never-users, the reported hazard ratio was 2.19 (95% CI 1.12–4.27) — in plain terms, about twice the rate of ovarian cancer over the follow-up period. Permanent hair dye, by contrast, showed essentially no association on ever-use (HR 1.07, 95% CI 0.82–1.39).

Two honest qualifications belong next to that number. The confidence interval is wide, which is what happens when 241 cases are spread across a large cohort — the finding is real but imprecise. And this cohort was about 84 percent non-Hispanic White and 8 percent Black, so it is not a study about Black women specifically, and should not be presented as one. Every figure, cohort size and citation is set out in the study evidence ledger.

The mechanism the study authors describe is chemical rather than mechanical: endocrine-disrupting compounds present in these products, including parabens, phthalates, bisphenol A, metals and formaldehyde-releasing agents. A 2018 laboratory analysis of 18 hair-care products marketed to Black women targeted 66 endocrine disruptors and detected 45 of them; 84 percent of the chemicals detected were not listed on the label.

Study findings and adverse-event reports describe associations; they are not verified causation.

Do you qualify?

Eligibility is decided by a review of your own use history and records, not by a web page. This page will not tell you that you qualify in order to get you into a form, and it does not hand you to a lead broker: some matters may be referred to or handled with other law firms, and you are told which before anything happens.

  • Used a chemical hair relaxer at least four times a year for at least two years. Salon and at-home use both count — a perm at the kitchen sink every few months counts the same as a standing salon appointment — and use that ended long ago still counts. Nobody is asked whether it was done correctly.
  • A diagnosis of ovarian cancer — or uterine or endometrial cancer, which are in the same core group.
  • Documentation of the diagnosis: pathology, oncology records, operative reports.
  • A rough timeline of use, and whatever brand memory you have. Not remembering brands is common and does not end a claim.
  • The filing deadline in your state has not run. Deadlines vary by state and some are short, which is why they get checked first. The clock generally runs from when you knew or should have known of the connection between the product and the diagnosis, not from your last relaxer.

The eligibility walkthrough explains what a review looks at and in what order. The first step is about two minutes, costs nothing, and asks nothing you have to find first — records are requested for you, with your authorization.

What this page is not

This page is legal information, not medical advice, and it does not diagnose anything. Questions about your health belong with your own doctor.

No hair relaxer settlement has been announced and no one has been paid. Any page that quotes a dollar figure is estimating. Pages that publish ranges are reasoning from other litigations, not from anything that has happened in this one — the settlement page explains where those numbers actually come from.

Consultations are free and confidential, and there is no fee unless there is a recovery. Some matters may be referred to or handled with other law firms.

A claim here is against the companies that made and sold the product — not against a salon, not against whoever applied it, and not against you for having used it. Would it be wrong to spend two minutes finding out where you stand? You get an answer either way, including the answer that there is nothing here for you.

Free, Confidential Consultation — no fee unless there is a recovery

Talk to Marin & Murphy Law Firm at (888) 348-2735 — answered 24/7 — or use the confidential case review form on this page. Some matters may be referred to or handled with other law firms.

The attorney’s fee is a percentage of the gross recovery, calculated before case expenses are deducted. Case expenses are advanced by the firm and reimbursed to the firm out of the recovery only if there is a recovery. You have no liability for court costs or litigation expenses if there is no recovery, unless a court directs otherwise.

Frequently Asked Questions

Ovarian cancer runs in some families. Does family history disqualify me?

Not automatically. Family history and genetic findings such as BRCA are part of the medical picture a review examines, and they cut both ways in litigation. They are a reason to have the file looked at carefully, not a reason to assume the answer.

Is this a class action?

No. These are consolidated individual lawsuits (an MDL) — 11,779 pending as of the panel’s August 3, 2026 count, out of 16,199 filed to date. Each case keeps its own facts and its own outcome.

The study was mostly White women. Does it still apply to me?

It applies as evidence about the products, not about a population. The ovarian finding comes from a predominantly White cohort; the uterine cancer findings come from both that cohort and a large study of Black women. We describe each study by what it actually measured.

What if my relaxer use was at a salon and I never bought the product?

Salon use counts. The screen is about how often and how long you were exposed, not about who bought the container.

What happens after I contact a firm?

A conversation about your use history and diagnosis, then, if the claim moves forward, authorizations so medical records can be obtained and reviewed. Nothing is filed on assumptions; the records decide.

What does “no fee unless there is a recovery” mean?

The attorney’s fee is a percentage of the gross recovery, calculated before case expenses are deducted. Case expenses are advanced by the firm and reimbursed to the firm out of the recovery only if there is a recovery. You have no liability for court costs or litigation expenses if there is no recovery, unless a court directs otherwise.

Sources
  • In re Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation, MDL No. 3060, N.D. Ill., Master Docket 1:23-cv-00818.
  • Dkt. 946, Memorandum Opinion and Order (Nov. 13, 2024) — core cancer claims and refiling window.
  • Dkt. 1944 (June 22, 2026) — “the … MDL injury (i.e., ovarian or uterine cancer).”
  • Dkt. 1781 (Apr. 2, 2026) — ten bellwether trial cases selected by the court.
  • Dkt. 1778 (Apr. 1, 2026) — expert discovery closes Nov. 16, 2026; dispositive motions due Dec. 16, 2026.
  • Dkt. 1828 (May 5, 2026); Dkt. 1881 — general-causation Rule 702 motion; briefed June 16, 2026; undecided.
  • JPML, Pending MDL Dockets by Actions Pending, Aug. 3, 2026.
  • White AJ, Sandler DP, Gaston SA, Jackson CL, O’Brien KM, “Use of hair products in relation to ovarian cancer risk,” Carcinogenesis 2021;42(9):1189–1195.
  • Chang C-J, O’Brien KM, Keil AP, et al., JNCI 2022;114(12):1636–1645 — mechanism discussion.
  • Helm JS, et al., Environmental Research 2018 (Silent Spring Institute) — 45 of 66 endocrine disruptors detected; 84% not on label.

Cases are handled on a contingent-fee basis: no fee unless there is a recovery. The attorney’s fee is a percentage of the gross recovery, calculated before case expenses are deducted. Case expenses are advanced by the firm and reimbursed to the firm out of the recovery only if there is a recovery. You have no liability for court costs or litigation expenses if there is no recovery, unless a court directs otherwise.